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Abstract
There is growing evidence that environmental toxicants can affect various physiological processes by altering DNA methyl-
ation patterns. However, very little is known about the impact of toxicant-induced DNA methylation changes on gene ex-
pression patterns. The objective of this study was to determine the genome-wide changes in DNA methylation concomitant
with altered gene expression patterns in response to 3, 3’, 4, 4’, 5-pentachlorobiphenyl (PCB126) exposure. We used PCB126
as a model environmental chemical because the mechanism of action is well-characterized, involving activation of aryl hy-
drocarbon receptor, a ligand-activated transcription factor. Adult zebrafish were exposed to 10 nM PCB126 for 24 h (water-
borne exposure) and brain and liver tissues were sampled at 7 days post-exposure in order to capture both primary and sec-
ondary changes in DNA methylation and gene expression. We used enhanced Reduced Representation Bisulfite Sequencing
and RNAseq to quantify DNA methylation and gene expression, respectively. Enhanced reduced representation bisulfite se-
quencing analysis revealed 573 and 481 differentially methylated regions in the liver and brain, respectively. Most of the dif-
ferentially methylated regions are located more than 10 kilobases upstream of transcriptional start sites of the nearest
neighboring genes. Gene Ontology analysis of these genes showed that they belong to diverse physiological pathways in-
cluding development, metabolic processes and regeneration. RNAseq results revealed differential expression of genes re-
lated to xenobiotic metabolism, oxidative stress and energy metabolism in response to polychlorinated biphenyl exposure.
There was very little correlation between differentially methylated regions and differentially expressed genes suggesting
that the relationship between methylation and gene expression is dynamic and complex, involving multiple layers of
regulation.
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Introduction
One of the extensively studied epigenetic effects of environ-
mental chemicals is altered DNA methylation, a covalent modi-
fication of cytosine nucleotides in a CG dinucleotide context
and an important mechanism of gene regulation. Toxicant ef-
fects on the DNA methylation process demonstrated so far in-
clude alterations in the expression of genes encoding DNA
methyltransferases (DNMTs), the availability of DNA methyla-
tion substrates and the degree of CpG methylation in different
regions of the genome. The majority of studies to date have fo-
cused on gene or locus-specific changes in DNA methylation.
With the advent of high throughput bisulfite sequencing meth-
ods such as reduced representation bisulfite sequencing (RRBS)
and whole genome bisulfite sequencing (WGBS), it has become
possible to measure genome-wide changes in DNA methylation
at base pair (bp) resolution [1, 2]. These methods have enabled
identification of differentially methylated regions (DMRs) in di-
verse genomic locations including promoters, CpG islands, gene
bodies and intergenic regions. As DNA methylation is one of the
key mechanisms for regulating gene expression, concomitant
analysis of the transcriptome and DNA methylome have been
conducted to demonstrate the role of DNA methylation in tran-
scriptional regulation. Recent studies have demonstrated very
little correlation between these two processes [3–5]. Similar
studies investigating the impact of environmental chemicals on
DNA methylation and gene expression are lacking except for
one study on the effect of vinclozolin on DNA methylation and
gene expression [6, 7].
Persistent organic pollutants such as polychlorinated biphe-
nyls (PCBs) are ubiquitously distributed in the environment and
exert a wide range of toxic effects. The most toxic PCBs are non-
ortho substituted congeners (dioxin-like PCBs) such as 3, 3’, 4, 4’,
5-pentachlorobiphenyl (PCB126). There is accumulating evi-
dence that exposure to PCBs can cause a number of metabolic,
behavioral and neurodevelopmental defects. The mode of ac-
tion of dioxin-like PCBs is well understood; it involves activation
of aryl hydrocarbon receptor (AHR), a ligand-activated transcrip-
tion factor [8]. There is extensive knowledge of target genes reg-
ulated by the AHR [9], but there is very limited information on
whether the effects of AHR ligands on these genes involve
changes in DNA methylation. Recent studies have demon-
strated an association between PCB exposure and altered DNA
methylation in humans [10–14]. In addition, exposure to dioxin-
like PCBs has been shown to cause changes in DNMT gene ex-
pression and gene-specific DNA methylation [15–20]. Very few
studies have determined genome-wide changes in DNA methyl-
ation in response to AHR agonists [21]. The objective of this
study is to identify genome-wide changes in DNA methylation
concomitant with gene expression patterns in the liver and
brain tissues of zebrafish exposed to PCB126. We hypothesized
that DNA methylation changes play a role in altered gene ex-
pression in response to PCB126 exposure.
Zebrafish is a well-established toxicology model system and
has been used to study the developmental toxicity of dioxin-
like PCBs [22], as well as the latent effects of developmental ex-
posure [23, 24]. The DNA methylomes of different life history
stages of developing zebrafish, as well as adult tissues have
been sequenced [25–28]. We have previously shown that devel-
opmental exposure to the potent AHR ligand, 2, 3, 7, 8-tetra-
chlorodibenzo-p-dioxin (TCDD or dioxin) altered the expression
of DNMTs and differentially methylated the CpG islands in the
promoter regions of some AHR target genes in zebrafish [29].
However, the relationship between genome-wide changes in
DNA methylation and altered patterns of gene expression in re-
sponse to any AHR ligand is unknown, in any model system.
Our results demonstrate that PCB126 exposure alters DNA
methylation across the genome with the majority of the sites lo-
calizing to the distal promoter regions in both liver and brain
tissues. Transcriptional profiling suggests that there is very lit-
tle concordance between these DNA methylation changes and
gene expression patterns.
Materials and Methods
Experimental Animals
Adult TL (Tupfel/Long fin mutations) strain of zebrafish was
used in this study. The zebrafish were maintained in a 10 l tank
(density of 2 fish per litre) at 28C system water with a 14-h
light, 10-h dark cycle. The fish were fed twice daily; morning
feeding with freshly hatched brine shrimp (Artemia salina) and
afternoon feeding with GEMMA Micro 300 microencapsulated
diet (Skretting USA, Tooele, Utah). The procedures used in this
study were approved by the Animal Care and Use Committee of
the Woods Hole Oceanographic Institution.
PCB126 Exposure
Adult male and female zebrafish (6 months old) were exposed to
either 10 nM PCB126 or solvent carrier (0.01% DMSO) in system
water (475 mg/l Instant Ocean, 79 mg/l sodium bicarbonate and
53 mg/l calcium sulfate; pH 7.2) for 24 h. We chose a 24 h exposure
period in order to ensure AHR activation in both liver and brain
tissues. Exposures were carried out in 2 gallon capacity glass
aquarium tanks in 5 l of water at density of 1 fish per 1.25 l of wa-
ter. This concentration of PCB126 was chosen because it does not
elicit any overt morphological defects, but induces gene expres-
sion changes. This concentration is also ten times lower than the
concentration used in a previous study where zebrafish juveniles
(2 months old) were exposed to PCB126 by a similar route of ex-
posure [30]. We chose 6 month old fish (standard length
23.563.5 mm) for this experiment for practical reasons of dis-
secting liver and brain tissues. Zebrafish are considered as adults
starting from 3 months of age to 2 years [31].
Each treatment had 4 biological replicates (2 males and 2 fe-
males). At the end of the exposure, fish were transferred to
clean water with constant aeration and heating and maintained
for 7 days. Fish were not fed during the 24 h exposure period.
During the 7 days post-exposure, the husbandry conditions
were the same as described in the previous section. At 7 days
post-exposure, fish were euthanized with MS-222 (150 mg/l)
buffered with sodium bicarbonate (pH 7.2) prior to tissue sam-
pling. We chose this experimental design in order to capture
both primary and secondary changes in DNA methylation and
gene expression. Liver and brain tissues were dissected and
snap frozen in liquid nitrogen and stored at –80C until nucleic
acids were isolated.
Isolation of Total RNA and Genomic DNA
Simultaneous isolation of genomic DNA and total RNA was per-
formed using the ZR-DuetTM DNA/RNA MiniPrep kit (Zymo
Research, CA). RNA was treated with DNase during the isolation
process. DNA and RNA were quantified using the Nanodrop
Spectrophotometer. The quality of DNA and RNA was checked
using the Agilent 4200 and 2200 TapeStation systems, respec-
tively. The DNA and RNA integrity numbers of all samples were
between 9 and 10.
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Quantitative Real-Time PCR
Complementary DNA was synthesized from 1 lg total RNA us-
ing the iScript cDNA Synthesis Kit (Bio-Rad, CA). Quantitative
PCR was performed with iQ SYBR Green Supermix in a MyiQ
Single-Color Real-Time PCR Detection System (Bio-Rad, CA).
Real-time PCR primers used for amplifying b-actin were
5’-CAACAGAGAGAAGATGACACAGATCA-3’ (Forward) and
5’-GTCACACCATCACCAGAGTCCATCAC-3’ (Reverse). These
primers amplify both b-actin paralogs (actb1 and actb2). Cyp1a
forward and reverse primers were 5’-GCATTACGATACGTTC
GATAAGGAC-3’ and 5’-GCTCCGAATAGGTCATTGACGAT-3’,
respectively.
The PCR conditions used were 95C for 3 min (1 cycle) and
95C for 15 s/65C for 1 min (40 cycles). At the end of each PCR
run, a melt curve analysis was performed to ensure that only a
single product was amplified. Three technical replicates were
used for each sample. A no-template control was included on
each plate to ensure the absence of background contamination.
We did not observe any significant differences in b-actin levels
between DMSO and PCB126 both in qPCR and in our RNAseq
data. Relative expression was normalized to that of b-actin
(2–DCt; where DCt¼ [Ct(cyp1a)–Ct(b-actin)]). One-way ANOVA was
used to determine the effect of PCB126 on cyp1a induction
(GraphPad Prism version 5.3). A probability level of P< 0.05 was
considered statistically significant.
Enhanced Reduced Representation Bisulfite Sequencing
and Data Analysis
Enhanced reduced representation bisulfite sequencing (eRRBS)
library preparation and sequencing was conducted by
ZymoResearch. Briefly, libraries were prepared from 200–500 ng
of genomic DNA digested with 60 units of TaqaI and 30 units of
MspI (New England Biolabs, MA) sequentially and then ex-
tracted with DNA Clean and ConcentratorTM-5 kit
(ZymoResearch, CA). Fragments were ligated to pre-annealed
adapters containing 5’-methylcytosine instead of cytosine ac-
cording to Illumina’s specified guidelines. Adaptor-ligated frag-
ments of 150–250 bp and 250–350 bp in size were recovered from
a 2.5% NuSieve 1 : 1 agarose gel (ZymocleanTM Gel DNA
Recovery Kit). The fragments were then bisulfite-treated using
the EZ DNA Methylation-LightningTM Kit. Preparative-scale PCR
was performed and the resulting products were purified and 50
bp paired end (PE) sequencing was performed on an Illumina
HiSeq2500 platform. Sequence reads from eRRBS libraries were
identified using standard Illumina base-calling software.
Raw reads were pre-processed using TrimGalore and aligned
to the zebrafish genome (GRCz10) using the Bismark alignment
software [32] with maximum 2 mismatches, and only uniquely
aligned reads were retained for subsequent analysis. Index files
were generated using the bismark_genome_preparation command
and the entire reference genome. The –non_directional parameter
was applied while running Bismark. All other parameters were
set to default. Filled-in nucleotides were trimmed off when do-
ing methylation calling. The methylation level of each sampled
cytosine was estimated as the number of reads reporting a C, di-
vided by the total number of reads reporting a C or T.
Differentially methylated CpG regions were analysed using
methylKit [33]. Sex of the fish was used as a co-variate in the
analysis. Briefly, the numbers of methylated and unmethylated
CpG sites were counted for each region and descriptive statistics
such as read coverage and percentage methylation were
calculated for each sample. Samples were filtered based on read
coverage and any reads with<10x coverage were discarded. We
further filtered the reads by only selecting the CpG sites covered
in all the samples. To determine differential methylation, we
used the tiling window approach with a 300 bp window length
and 300 bp step-size. The logistic regression method was used
to calculate P-values. We empirically determined that the
300 bp window length was appropriate in our case as the major-
ity of the tiles had approximately the same number of CpG sites
and the DMRs were not fragmented into multiple small regions.
The SLIM method [34] was used to calculate q-values. We used a
q-value of less than 0.01 and percent methylation difference
larger than 25% as the statistical cutoff for determining DMRs.
We used the Genomation package [35] to classify the DMRs into
different genomic regions. Genomic coordinates of zebrafish
refseq genes, CpG islands and repeat sequences were down-
loaded from the UCSC genome browser. CpG shores were de-
fined as 2000 bp flanking regions on upstream and downstream
of a given CpG island.
DMR Gene Ontology Enrichment Analysis
We used Genomic Regions Enrichment of Annotations Tool
(GREAT) to associate DMRs with genes [36]. GREAT predicts gene
functions of cis regulatory elements by assigning each gene a
regulatory domain. To use GREAT, we converted the genomic
coordinates of DMRs from GRCz10 version to Zv9 version of the
genome using the UCSC genome browser liftOver utility (https://
genome.ucsc.edu/cgi-bin/hgLiftOver). We used default parame-
ters with a basal domain that extends 5 kb upstream and 1 kb
downstream of the TSS and conducted gene ontology (GO) (bio-
logical process and molecular function) enrichment analysis.
RNA Sequencing and Data Analysis
Unstranded RNAseq library preparation using the Illumina
TruSeq total RNA library prep kit and 50 bp single-ends se-
quencing on the HiSeq2000 platform were performed at the
Tufts University Core Facility. Raw data files were assessed for
quality using FastQC [37] and pre-processed as described previ-
ously [38]. Pre-processed reads were mapped to the genome. We
used Ensembl version 84 (GRCz10) of the zebrafish genome and
annotations (gtf) in this analysis [39]. HTSeq-count was used to
obtain the number of reads mapped to annotated regions of the
genome [40]. Statistical analysis was conducted using edgeR, a
Bioconductor package [41], using sex as an independent vari-
able. Only genes with false discovery rate (FDR) of less than 5%
were considered to be differentially expressed. Raw data has
been deposited into Gene Expression Omnibus (accession num-
ber GSE104221).
GO analysis of differentially expressed genes (DEGs) was
done using gProfiler [42]. Zebrafish ensembl IDs were used as in-
put and Bonferroni correction for multiple testing (P-val-
ue<0.05) was used while determining the fold enrichment. To
understand the relationship between GO terms, Directed
Acyclic Graphs of significantly enriched GO terms were drawn
using GOView (webgestalt.org/GOView).
Comparing DNAMethylation Changes with
Gene Expression
To determine the overlap between DMRs and gene expression,
we compared the gene annotation of DMRs obtained from
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GREAT analysis with the DEGs determined by RNA-seq. For the
set of overlapping genes, we determined the Spearman’s corre-
lation coefficient between difference in methylation of the DMR
and the altered expression of the target gene.
Results
Cyp1a Gene Expression
To confirm the activation of AHR by PCB126, we quantified
cyp1a gene expression using quantitative real-time PCR (Fig. 1).
We observed 48-fold and 672-fold increase in cyp1a expression
in liver and brain, respectively. The higher fold increase in cyp1a
expression in the brain compared to liver is partly due to a lower
basal expression.
DNAMethylation Profiling
We used enhanced RRBS (eRRBS) to identify DMRs in response
to PCB126 exposure. eRRBS is a modified version of RRBS that
includes fragments of MspI (CˆCG_G) and Taqa1 (AˆCG_T) restric-
tion enzyme digest and captures CpG sites beyond the CpG is-
lands [43]. RRBS and eRRBS have been previously used to profile
baseline DNA methylation in adult zebrafish tissues [28, 44] and
in response to toxicants [45].
Using eRRBS, we sequenced an average of 34 million and
31.66 million paired-ends reads from liver and brain samples,
respectively. The bisulfite conversion efficiency was 98–99%.
The mapping efficiency of these reads to the bisulfite converted
zebrafish genome was between 36% and 38%, which is compa-
rable to previously published studies in zebrafish [28, 44].
On average, 257 million cytosines were sequenced. Of these 28.5
and 15.2 million were methylated and unmethylated, respec-
tively, in a CpG context. In both liver and brain tissues, we se-
quenced approximately 1.25 million unique CpGs per sample
with 10x coverage. A detailed summary of the number of CpGs
and their coverage is provided in the Supplementary Material
(eRRBS_summary_statistics.xlsx).
Using a 300-bp tiling window size, we observed 125 008
unique tiles that were represented in all eight liver samples.
The number of unique 300 bp tiles that were shared among all
eight brain samples was 103 673. Based on the analysis of all the
samples, the genome wide methylation level in the liver and
brain was found to be 66.87% and 63.12%, respectively.
Methylation level was low in the promoter regions and CpG is-
lands (Fig. 2A and B). Annotation of these tiles revealed that the
majority of the CpGs are located in the distal promoter regions
in both tissues (Fig. 2C). Only 8% of the features are associated
with CpG islands and shores (Fig. 2C).
PCB126-Induced Changes in DNAMethylation in
the Liver
Differential methylation analysis revealed a total of 573 DMRs
in the liver in response to PCB126 exposure (Fig. 3A), out of
which 327 were hypomethylated and 246 were hypermethy-
lated. Only 59 hypomethylated DMRs (15% of total) and 47 hyper-
methylated DMRs (19% of total) showed a percent methylation
difference larger than or equal to 40%. DMRs were distributed
throughout the genome with no discernable patterns in their
chromosomal location. The complete list of liver DMRs is pro-
vided in the Supplementary Material (Liver_DMRs.xlsx).
The hypermethylated DMRs were enriched in GO biological
process terms such as otic placode development, positive regu-
lation of Wnt receptor signaling pathway and integrin-mediated
signaling pathway (Fig. 4A). The enriched GO molecular func-
tion terms include dopamine beta-monoxygenase activity, ino-
sitol 1, 4, 5-trisphosphate 3-kinase (IP3 3-kinase/IP3K) and GABA
receptor activity (Fig. 4B). The complete list of all GO terms, their
fold enrichment, the list of genes associated with each GO term
and the DMR distance from the transcriptional start site are pro-
vided in the Supplementary Material (Liver_DMR_GO_analysis.
xlsx).
GO analysis of hypomethylated DMRs revealed enrichment
of biological process terms such as negative regulation of apo-
ptosis, secretion, regulation of collateral sprouting and thyroid
gland development (Fig. 4A). The hypomethylated DMRs were
enriched in GO molecular function terms sugar-phosphatase
activity, transferase activity, transferring sulfur-containing
groups, thyroxine 5’-deiodinase activity, cGMP binding, intracel-
lular ligand-gated ion channel activity and heparan sulfate sul-
fotransferase activity (Fig. 4B).
PCB126-Induced Changes in DNAMethylation in
the Brain
In the brain, a total of 481 DMRs were observed with 294 hypo-
methylated and 187 hypermethylated regions (Fig. 3B). Only a
small proportion of these (19% of hypomethylated and 14% of
hypermethylated) showed a percent methylation difference
larger than 40%. Similar to the liver DMRs, the DMRs in the brain
were distributed randomly along chromosomes. The complete
list of brain DMRs is provided in the Supplementary Material
(Brain_DMRs.xlsx).
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Figure 1: PCB126-induced cyp1a gene expression in the liver (A) and brain (B).
Cyp1a expression relative to the reference gene was calculated using the delta Ct
method. b-Actin was used as a reference gene. * Represents significant differ-
ence from DMSO control (One-way ANOVA; P<0.01)
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Hypermethylated DMRs in the brain showed significant en-
richment of two GO molecular function terms (cyclin-depen-
dent protein kinase 5 activator activity and protein kinase
activator activity) and three biological process terms (piwi-inter-
acting RNA (piRNA) metabolic process, regulation of receptor ac-
tivity and monocarboxylic acid biosynthetic process) (Fig. 4C).
On the other hand, the hypomethylated DMRs were enriched in
GO molecular function terms such as acetylglucosaminyltrans-
ferase activity, GABA receptor activity and transcription regula-
tory region DNA binding (Fig. 4D). The complete list of all GO
terms, their fold enrichment, the list of genes associated with
each GO term and the DMR distance from the transcriptional
start site are provided in the Supplementary Material (Brain_
DMR_GO_analysis.xlsx).
PCB126-Induced Transcriptional Changes
We obtained an average of 32.3 and 30.6 million raw reads from
liver and brain samples, respectively. Of these, 83% (liver) and
88% (brain) of the reads were mapped uniquely to the zebrafish
genome. Multi-dimensional scaling indicated two liver samples
[one control (male) and one PCB126 treated (female)] to be out-
liers and hence these were not included in the differential ex-
pression analysis. These two samples had only 68% and 74% of
the reads uniquely mapped to the zebrafish genome. The sum-
mary of the raw data is presented in the Supplemental Material
(RNAseq_Summary.xlsx).
There were a total of 585 and 1715 DEGs in the liver and
brain, respectively (Fig. 5). Among the 585 DEGs in the liver, 300
were upregulated and 285 were downregulated. All DEGs in the
liver were altered by a fold change of 2 or higher even with a
FDR of 10% as a statistical cutoff (Supplementary Material –
Liver_DEGs.xlsx). The upregulated genes were enriched in GO
terms such as response to xenobiotic stimulus (biological pro-
cess), and acrosin binding (molecular function). Many of the
upregulated genes are known AHR target genes (Table 1). Cell
cycle and glutathione metabolism are the two KEGG pathways
enriched among the upregulated genes. The downregulated
genes in the liver represent pathways associated with sterol,
ion, oxygen and heme transport activity. The GO terms and the
associated genes for both up and downregulated genes in the
liver are shown in Table 2.
In the brain, PCB126 exposure resulted in the differential ex-
pression of 1715 genes. Among these 899 genes were upregu-
lated and 816 genes were downregulated (Fig. 5; Supplementary
Material – Brain_DEGs.xlsx). Similar to the responses in the
liver, genes associated with xenobiotic metabolism were upre-
gulated in the brain (Table 1). The GO terms (molecular func-
tion) enriched among the upregulated genes include acrosin
binding, actin binding and ribosomal constituents. The upregu-
lated KEGG pathway terms include metabolism of xenobiotics
by cytochrome P450 and ribosome. The downregulated genes in
the brain were enriched in GO terms (molecular function) such
as nucleoside-triphosphate activity, structural constituent of
cytoskeleton and tubulin binding. KEGG terms represented in-
clude dorso-ventral axis formation, FoxO signaling pathway,
ErbB signaling pathway and mRNA surveillance pathway. The
GO terms and the associated genes for both up and downregu-
lated genes in the brain are shown in Table 3.
Relationship between DMRs and Altered
Gene Expression
There was very little correlation between DMRs and gene ex-
pression patterns. In the liver, only nine genes were both differ-
entially methylated and differentially expressed. Of these, six
genes showed the expected inverse relationship between DNA
methylation and gene expression. In the brain, 33 genes showed
both altered methylation and altered gene expression and only
12 of these were inversely related (Table 4). For both liver and
brain, there was not a significant correlation between the de-
gree of altered DNA methylation and the degree of altered gene
expression (Spearman r2¼ 0.2719 for liver and 0.0078 for brain).
Discussion
AHR is a ligand activated transcription factor known to regulate
a wide variety of target genes upon PCB126 exposure. The re-
sults indicate that PCB126 exposure altered DNA methylation
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patterns mostly in the distal promoter regions (>10 kb).
Transcriptomic profiling revealed classical responses to dioxin-
like PCBs including upregulation of xenobiotic metabolism
genes and downregulation of genes associated with growth and
energy metabolism. However, the genes associated with DMRs
represent diverse physiological pathways in both tissues. We
observed very little overlap between DEGs and the genes associ-
ated with DMRs, suggesting distinct effects of PCB126 on DNA
methylation and gene expression. We attempted to capture
both the primary and secondary changes in DNA methylation
and gene expression by sampling at 7 days post-exposure. As
DNA methylation and transcription are dynamic processes, our
results represent a snapshot of the changes. In order to capture
the relationship between these processes multiple time points
need to be analysed.
The effects of dioxin and dioxin-like PCBs on DNA methyla-
tion have previously been demonstrated but most of these stud-
ies have used gene or locus-specific methods to measure DNA
methylation [15–18, 20, 29]. Using eRRBS we show that there are
strikingly high levels (>60%) of DNA methylation in the distal
promoter regions in zebrafish compared to other species [46].
Our results demonstrate differential methylation in response to
Figure 3: PCB126-induced tissue-specific changes in DNA methylation. Volcano plots showing DMRs in response to PCB126 exposure in the liver (A) and brain (B).
Percent methylation difference (x-axis) between PCB126 and Control are plotted against q-value (y-axis). Red vertical lines represent the 25% methylation difference
and the blue horizontal line represents a q-value of 0.05, which are used as a statistical cutoff in differential methylation analysis. Each green and red spot represents a
statistically significant hypo and hypermethylated region, respectively
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PCB126 exposure at multiple loci distributed throughout the ge-
nome in both tissues. We could not detect any sex-specific dif-
ferences, possibly due to small sample size (n¼ 2) and lack of
statistical power.
Differential Methylation in the Liver
In the liver, DMRs are associated with a variety of genes includ-
ing transcription factors, receptors, transporters, cell adhesion
molecules, endocrine and metabolic enzymes. Most of the
genes play an important role in hepatic development and re-
generation in response to injury. For instance, we observed
PCB126-induced hypermethylation of sox9a and sox9b genes,
which encode transcription factors critical for normal develop-
ment. In mammals, SOX9 is responsible for maintaining ho-
meostasis in the liver and the regenerative capacity is
dependent on SOX9-positive hepatic progenitor cells [47].
Similarly, in the zebrafish regeneration model, ablation of hepa-
tocytes causes transdifferentiation of biliary cells into hepato-
cytes and this process is blocked in sox9b mutants [48],
suggesting an important role in liver regeneration. Previous
studies have shown downregulation of sox9b expression with
AHR agonists in zebrafish embryos and in regenerating tissues
(caudal fin) [49–52]. However, we did not observe differential ex-
pression of sox9b in either the liver or brain, suggesting tissue-
specific differences in its regulation. As SOX9 genes are master
regulators of cell fate and tissue morphogenesis, it is possible
that their expression is regulated by multiple mechanisms in-
cluding DNA methylation.
One such mechanism of sox9b regulation is by non-coding
RNA. A recent study has demonstrated that a long intervening
non-coding RNA (lincRNA; si: ch1073–384e4.1) regulates the ex-
pression of sox9b in zebrafish embryos [53]. We also observed
significant upregulation of this lincRNA in response to PCB126
exposure (4.5 log FC; FDR 6.03E–12), suggesting multiple modes
of action of AHR agonists in altering sox9b expression in zebra-
fish. Garcia et al. [53] also demonstrated that this lincRNA ex-
pression is AHR-dependent and is required for sox9b expression
during normal development.
Other hypermethylated genes that are critical for liver
growth and regeneration include hepatocyte growth factor
(hgfa) and fibroblast growth factor 8a (fgf8a). Hgfa is an acute
phase protein induced in the liver in response to injury and is
required for liver regeneration [54, 55]. Fgf8a is a member of the
FGF family of growth factors and a morphogen [56]. Given the
role of these genes in repair and regeneration, it is possible that
hypermethylation (and therefore downregulated expression) of
these genes exacerbate injury by reduced regeneration.
Another important enriched pathway among the hyperme-
thylated DMRs includes thyroid hormone signaling. We ob-
served hypermethylation of paired box 8 (pax8) and
iodothyronine deiodinase genes (dio2 and dio3a). Pax8 is a tran-
scription factor involved in thyroid differentiation and its al-
tered expression by either mutations or epigenetic
modifications disrupts thyroid morphogenesis leading to a vari-
ety of phenotypes ranging from thyroid agenesis, ectopia and
hypoplasia [57]. Dio2 catalyzes the conversion of prohormone
thyroxine (T4) to the bioactive thyroid hormone (T3), and dio3a
converts T4 and T3 into inactive metabolites. As liver has an im-
portant role in thyroid hormone metabolism and hypothyroid-
ism is linked to liver diseases [58], it is possible that altered
methylation of these genes could affect downstream signaling.
It is very well documented that dioxins and dioxin-like
PCBs cause hypothyroidism by altering thyroid hormone levels
[59–62]. Concomitant with hypermethylation of dio2, we ob-
served a decrease in its expression, suggesting a potential
mechanism of action of PCB126 in causing hypothyroidism. In
addition, we also observed hypermethylation of genes that en-
code sulfotransferases (gal3st1, hs3st2, hs3st4, hs6st1a, ndst3,
nfs1, sult6b1), key players in the metabolism of xenobiotics,
drugs and endogenous hormones. Hydroxylated PCBs, the met-
abolic byproducts of PCBs, disrupt endocrine signaling by in-
hibiting sulfotransferases [63]. Indeed there is an association
between increased body burden of hydroxylated PCBs and al-
tered thyroid hormone status in humans [64]. It remains to be
determined if altered methylation of these genes is a potential
mechanism of action of dioxin-like PCBs. Our RNAseq data do
not reveal differential expression of these genes.
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Figure 5: Tissue-specific gene expression changes. MA plots showing the DEGs in the liver (A) and brain (B). Horizontal blue lines represent fold change of6 2. Each red
spot represent a statistically differentially expressed gene
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We also observed several hypomethylated DMRs in the liver
and enrichment analysis revealed these DMRs to be associated
with transcription factors belonging to the homeobox family
(dmbx1b, pax2a, pbx2, pbx4, lhx9), nuclear receptor superfamily
(nr2f2) and others (gata5). We did not find any studies demon-
strating the involvement of these transcription factors in liver
metabolism or their altered DNA methylation or gene expres-
sion in response to dioxin-like PCB exposure. However, these
transcription factors are important players in early cellular dif-
ferentiation suggesting that altered methylation could affect tis-
sue differentiation and regeneration capacity in response to
injury.
Differential Methylation in the Brain
In contrast to the liver, hypermethylated DMRs in the brain did
not show significant enrichment of many GO terms. Among the
enriched GO terms, one that is particularly interesting is piRNA
metabolic process. piRNAs are 23–32 nucleotide single
stranded RNA molecules derived from the intergenic regions or
3’ untranslated regions of mRNAs. They are involved in trans-
posable element (TE) repression [65] and preserving genomic in-
tegrity [66, 67]. piRNAs were originally discovered in the
germline, but their presence and function in somatic cells in-
cluding neurons has been reported [68, 69]. Defects in piRNA
production result in TE de-repression and cell death. We ob-
served hypomethylation of HEN methyltransferase (henmt1) and
tudor domain containing protein 1 (tdrd1) genes, key players in
piRNA biogenesis. Henmt1 adds a 2’-O-methyl group at the 3’-
end of piRNAs and protects the 3’-end of piRNAs from degrada-
tion. In zebrafish, loss of henmt1 has been shown to reduce
piRNA content in oocytes and cause female sterility. Tdrd1 acts
as a molecular scaffold for piwi proteins and is required for
proper functioning of the piRNA pathway. If hypomethylation
of these genes could lead to increased gene expression and sub-
sequently to an increase in piRNA production, it is possible that
this is in response to an increase in TE re-activation and retro-
transposition in the brain resulting from PCB126 exposure. We
observed significant induction of tdrd1 expression in the brain
(logFC 4.03; FDR 0.01) suggesting increased piRNA biosynthesis
Table 1: Representative xenobiotic responsive genes differentially expressed in liver and brain in response to PCB126 exposure
Gene name Gene symbol Liver Brain
logFC FDR logFC FDR
AHR repressor a ahrra 10.677 7.21E–46 3.850 1.12E–02
AHR repressor b ahrrb 7.500 4.89E–04 2.669 3.68E–02
AHR interacting protein aip 0.553 3.90E–02
AHR nuclear translocator-like 1a arntl1a –0.694 2.71E–02
AHR nuclear translocator-like 1b arntl1b –0.792 3.38E–02
AHR nuclear translocator-like 2 arntl2 –1.758 2.75E–03 –1.033 2.53E–02
Cytochrome P4501a cyp1a 5.420 3.40E–20 8.571 8.60E–85
Cytochrome P4501b1 cyp1b1 7.750 1.35E–16 1.834 3.11E–03
Cytochrome P450, family 1, subfamily C, polypeptide 1 cyp1c1 5.433 6.30E–17 4.745 7.26E–06
Cytochrome P450, family 1, subfamily C, polypeptide 2 cyp1c2 2.887 2.44E–06 3.058 6.81E–03
Cytochrome P450, family 2, subfamily AA, polypeptide 12 cyp2aa12 1.443 3.88E–02
Cytochrome P450, family 2, subfamily AA, polypeptide 4 cyp2aa4 2.662 2.04E–02
Cytochrome P450, family 2, subfamily K, polypeptide 22 cyp2k22 –5.654 2.50E–02
Cytochrome P450, family 2, subfamily K, polypeptide 31 cyp2k31 –5.169 3.10E–07
Cytochrome P450, family 2, subfamily K, polypeptide 6 cyp2k6 8.607 1.52E–02
Cytochrome P450, family 2, subfamily X, polypeptide 10.2 cyp2x10.2 3.495 2.32E–10
Cytochrome P450, family 2, subfamily AD, polypeptide 3 cyp2ad3 1.055 1.79E–02
Cytochrome P450, family 2, subfamily P, polypeptide 6 cyp2p6 1.005 6.51E–03
Cytochrome P450, family 2, subfamily V, polypeptide 1 cyp2v1 1.348 9.56E–03
Cytochrome P450, family 26, subfamily b, polypeptide 1 cyp26b1 0.985 9.56E–03
Glutathione S-transferase theta 1b gstt1b 1.349 4.30E–02
Microsomal glutathione S-transferase 3b mgst3b 2.050 7.38E–04 0.762 1.18E–02
Glutathione S-transferase theta 1a gstt1a 3.983 3.73E–02
Glutathione S-transferase mu, tandem duplicate 1 gstm.1 0.619 3.15E–02
Glutathione S-transferase rho gstr 0.768 3.90E–02
Glutathione S-transferase pi 1 gstp1 0.883 3.43E–02
Glutamate-cysteine ligase, modifier subunit gclm 1.779 1.52E–03
Glutathione reductase gsr 1.498 3.79E–03
Glucose-6-phosphate dehydrogenase g6pd 1.610 1.96E–02
NAD(P)H dehydrogenase, quinone 1 nqo1 1.951 3.42E–02
Kelch-like ECH-associated protein 1b keap1b 1.308 4.11E–02
UDP glucuronosyltransferase 1 family, polypeptide B5 ugt1b5 1.633 2.20E–02
UDP glucuronosyltransferase 1 family, polypeptide B1 ugt1b1 1.667 6.72E–03
UDP glucuronosyltransferase 1 family, polypeptide B2 ugt1b2 –2.217 3.98E–02
UDP glucuronosyltransferase 1 family, polypeptide B7 ugt1b7 –2.779 8.30E–05
UDP glucuronosyltransferase 5 family, polypeptide C2 ugt5c2 –2.099 1.03E–02
UDP glucuronosyltransferase 1 family, polypeptide A6 ugt1a6 4.251 3.13E–02
Phosphogluconate dehydrogenase pgd 1.856 4.99E–03
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to suppress TE activation. Previous studies have demonstrated
that xenobiotics can cause TE activation [70, 71].
In the brain, many of the hypomethylated DMRs are associ-
ated with genes related to the Wnt/b – catenin signaling path-
way, crucial for the formation of the blood-brain barrier (BBB)
[72]. BBB is a semi-permeable barrier that restricts the move-
ment of ions and molecules between the blood and brain, and
its disruption can lead to inflammation. We observed hypo-
methylation of a Wnt ligand (Wnt4a), a Wnt signaling antago-
nist (dkk1a) and associated genes (ctnnbip1, ascl1a). In addition,
we observed hypomethylation of cell adhesion genes
[cadherins (cdh2, cdh6) and protocadherins (pcdh10b, pcdh15a,
pcdh17, pcdh18b, pcdh1a, pcdh2g12)], which are modulated by
Wnt/b – catenin signaling. Cell adhesion genes are critical for
the development and maintenance of proper vascular net-
works such as the BBB [73]. It is not yet clear how hypomethy-
lation of these gene regulatory regions can alter their
expression. We did not observe differential expression of
these genes in our RNAseq data, but other cell adhesion genes
(cdh2, cdh7, cdh17, cdh18a, pcdh2g5) were differentially ex-
pressed. Previous research in murine models has shown that
endothelial cells and astrocytes are targets of AHR-dependent
TCDD toxicity [74].
It remains to be determined how DNA methylation is regu-
lated by AHR ligands. We have previously demonstrated that
TCDD exposure alters DNMT gene expression patterns in devel-
oping embryos. Furthermore, we have shown in vitro that XREs
Table 2: GO and KEGG pathway analysis of DEGs in the liver (A)
Upregulated genes and (B) downregulated genes in the liver were
analysed separately for enrichment of GO biological process and mo-
lecular function terms and KEGG pathways
A
Term ID Name Adjusted P-value
GO: 0009410 Response to xenobiotic
stimulus
0.002
GO: 0032190 Acrosin binding 0.000152
KEGG
KEGG: 04110 Cell cycle 0.0000199
B
Term ID Name Adjusted P-value
Biological process
GO: 0015669 Gas transport 0.0000129
GO: 0006820 Anion transport 0.000632
GO: 0010873 Positive regulation of
cholesterol
esterification
0.00185
GO: 0033700 Phospholipid efflux 0.00185
GO: 0065005 Protein-lipid complex
assembly
0.00185
GO: 0055088 Lipid homeostasis 0.00365
GO: 0006695 Cholesterol biosynthetic
process
0.0141
Molecular function
GO: 0015248 Sterol transporter
activity
0.00123
GO: 0060228 Phosphatidylcholine-
sterol-O-acyltransfer-
ase activator activity
0.00185
GO: 0005344 Oxygen transporter
activity
0.00365
GO: 0019825 Oxygen binding 0.00365
GO: 0020037 Heme binding 0.0376
GO: 0015485 Cholesterol binding 0.0417
GO: 0005215 Transporter activity 0.0463
KEGG
KEGG: 00910 Nitrogen metabolism 0.0386
Table 3: GO and KEGG pathway analysis of DEGs in the brain (A)
Upregulated genes and (B) downregulated genes in the brain were
analysed separately for enrichment of GO biological process and mo-
lecular funtion terms and KEGG pathways
A
Term ID GO term Adjusted P-value
Biological process
GO: 0006412 Translation 0.0000253
GO: 0009410 Response to xenobiotic
stimulus
0.0000854
GO: 0003012 Muscle system process 0.000151
GO: 0060326 Cell chemotaxis 0.00487
GO: 0045861 Negative regulation of
proteolysis
0.0158
GO: 0043902 Positive regulation of
multi-organism
process
0.0161
GO: 0009605 Response to external
stimulus
0.024
Molecular function
GO: 0003735 Structural constituent of
ribosome
9.07E–13
GO: 0003779 Actin binding 0.0000803
GO: 0032190 Acrosin binding 0.0299
KEGG
KEGG: 03010 Ribosome 1.66E–11
KEGG: 00980 Metabolism of xenobi-
otics by cytochrome
P450
0.000786
B
Term ID GO term Adjusted P-value
Biological process
GO: 0016043 Cellular component
organization
2.28E–15
GO: 0060627 Regulation of vesicle-
mediated transport
0.00154
GO: 0043087 Regulation of GTPase
activity
0.0023
GO: 0006836 Neurotransmitter
transport
0.00343
GO: 0035556 Intracellular signal
transduction
0.00659
Molecular function
GO: 0000902 Cell morphogenesis 0.0188
GO: 0017111 Nucleoside-triphospha-
tase activity
0.00641
GO: 0015631 Tubulin binding 6.44E–11
GO: 0008047 Enzyme activator
activity
0.00309
GO: 0005200 Structural constituent of
cytoskeleton
0.00375
GO: 0098772 Molecular function
regulator
0.0042
KEGG
KEGG: 04320 Dorso-ventral axis
formation
0.0043
KEGG: 04068 FoxO signaling pathway 0.0147
KEGG: 03015 mRNA surveillance
pathway
0.0167
KEGG: 04012 ErbB signaling pathway 0.0368
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in the DNMT proximal promoter regions influence DNMT ex-
pression [29]. However, further studies are necessary to deter-
mine the mechanism of action of AHR activation in altering
genome-wide DNA methylation patterns. We hypothesize that
AHR activation alters the accessibility of DNA to DNMTs by al-
tering the chromatin state.
PCB126 Induced Transcriptional Responses
We observed classical responses to PCB126 exposure in the liver
and brain, where genes associated with xenobiotic metabolism
were upregulated. Almost all of these are AHR target genes and
have been shown previously to be altered by dioxins and
dioxin-like PCBs in a variety of animals including zebrafish
(Table 1). In addition to cytochrome P450s, several oxidative
stress response (OSR) genes were upregulated in both tissues.
Glutathione (GSH) is critical for intracellular redox homeostasis
and protects against oxidative damage caused by reactive oxy-
gen species. It is well established that dioxin and dioxin-like
PCBs contribute to oxidative stress [75]. In this study, upregula-
tion of OSR genes suggest that PCB126-exposed fish are trying to
maintain cellular redox balance.
PCB126 exposure downregulated the expression of several
genes encoding lipid-binding and transport proteins in the liver
Table 4: Relationship between DMRs and DEGs (A) List of genes in the liver (A) and brain (B) that are both differentially methylated and differ-
entially expressed. Spearman correlation coefficient was not statistically significant (r2¼ 0.2719 for liver and 0.0078 for brain). There is an in-
verse relationship between DNA methylation (Meth. diff) and gene expression (logFC) for the genes highlighted in red
A
Gene symbol Gene name Meth. diff logFC
htr1aa 5-hydroxytryptamine (serotonin) receptor 1A a 28.32 –4.03
ttll3 Tubulin tyrosine ligase-like family, member 3 –25.7 –1.557
vtg1 Vitellogenin 1 –32.09 9.775
ywhag1 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide 1 28.76 –2.902
dio2 Iodothyronine deiodinase 2 34.52 –4.167
lmbr1l Limb development membrane protein 1-like –34.4 –1.419
cahz Carbonic anhydrase –29.53 –2.277
hla-dpa1 Major histocompatibility complex, class II, DP alpha 1 31.52 –1.796
baiap2a BAI1-associated protein 2a 30.13 –1.56
B
Gene symbol Gene name Meth. diff logFC
rpl37 Ribosomal protein L37 –28.42 1.071
eprs Glutamyl-prolyl-tRNA synthetase –25.48 –0.901
slc2a1a Solute carrier family 2 (facilitated glucose transporter), member 1a –25.14 –1.345
chmp3 Charged multi-vesicular body protein 3 29.91 0.805
cdh2 Cadherin 2, type 1, N-cadherin (neuronal) –28.68 –0.774
bcl11ba B-cell CLL/lymphoma 11Ba (zinc finger protein) –33.32 –0.767
tbl1xr1a Transducin (beta)-like 1 X-linked receptor 1a –33.25 –0.660
gnb1a Guanine nucleotide binding protein (G protein), beta polypeptide 1a –26.67 –1.063
tubb4b Tubulin beta-4B chain-like –26.76 –0.869
nup50 Nucleoporin 50 –26.44 –0.691
plek Pleckstrin –52.22 1.477
pcbp3 Poly(rC) binding protein 3 –29.15 –1.265
myom1a Myomesin 1a (skelemin) 37.24 5.298
zgc: 171776 L-rhamnose-binding lectin-like –28.79 9.483
pmp22a Peripheral myelin protein 22a –26.47 2.141
cldn15b Claudin 15b 36.93 0.694
ndufa3 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3 27.84 0.783
ppp1r37 Protein phosphatase 1, regulatory subunit 37 –39.50 –0.830
irf2bp2a Interferon regulatory factor 2 binding protein 2a –41.71 –0.605
zgc: 112001 Ankyrin repeat domain-containing protein 9-like 36.07 –0.761
klf2b Kruppel-like factor 2b –26.68 1.008
TMEM27 si: dkey-194e6.1 –26.84 4.635
kdm4b Lysine (K)-specific demethylase 4B 34.68 –0.575
pfdn5 Prefoldin 5 –29.96 0.797
grm8a Glutamate receptor, metabotropic 8a 26.53 –0.767
epha4a eph receptor A4a –39.15 –0.917
sult6b1 Sulfotransferase family, cytosolic, 6b, member 1 47.61 1.415
dpp9 Dipeptidyl-peptidase 9 –25.97 –0.608
gpc1b Glypican 1b 34.31 –0.953
ubap2a Ubiquitin associated protein 2a –27.07 –0.718
rgs4 Regulator of G protein signaling 4 31.24 0.793
rps17 Ribosomal protein S17 30.86 1.207
lrpap1 Low density lipoprotein receptor-related protein associated protein 1 –28.16 0.488
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including apolipoproteins (apoa1a, apoa4b.2, apoba, apoea, apoeb,
apol6), fatty acid binding proteins (fabp1b.1, fabp2) and solute
carriers. AHR-mediated disruption of hepatic lipid metabolism
has been well documented and altered expression of transport
proteins is the hallmark of dioxin-induced hepatic inflamma-
tion, non-alcoholic fatty liver disease and steatosis [76]. Our re-
sults agree with these findings that exposure to dioxin-like
PCBs alters lipid metabolism by altering the expression of lipid
transport proteins and suggest that the effects of PCBs on lipid
homeostasis are conserved among vertebrates. We also ob-
served downregulation of genes encoding heme-binding pro-
teins (cyp2k31, ido1, cyp2k22, hbba1, hbaa1, hbba1, hbaa2 and
PXDN) in the liver. Heme is critical for oxygen transport, energy
metabolism and drug biotransformation, and previous studies
have shown that exposure to AHR agonists’ increases cellular
heme levels to compensate for the increased demand
(e.g. cyp450 induction). Downregulation of these genes suggests
reduced demand for heme or dysregulation of the compensa-
tory mechanism potentially leading to metabolic disruption.
In the brain, we observed a relatively large number of DEGs
compared to the liver suggesting that the brain is sensitive to
exposure to environmental chemicals, particularly the neuro-
toxic effects of dioxin-like PCBs. We recently reported similar
findings where developmental exposure to low levels of PCB126
altered the expression of thousands of genes in the adult brain
[77]. The differences in the sensitivity of tissues to PCB exposure
at the molecular level are yet to be determined. In addition to
the induction of xenobiotic response genes, we observed upre-
gulation of a large number of ribosomal genes. This is in con-
trast to our previous observation that developmental exposure
to PCB126 caused downregulation of ribosomal genes in the
adult zebrafish brain [38], sugggesting that the effects on gene
expression vary depending on the duration and dose of expo-
sure as well as the life stage at which the exposure has oc-
curred. Ribosome biogenesis and protein synthesis are essential
for cellular differentiation and proliferation and any alterations
to these processes can severely impair cell growth. It has been
shown that xenobiotics, nutrient depletion and hypoxia can af-
fect ribosome biogenesis leading to ribosomal stress, a condi-
tion where unassembled ribosomal proteins are accumulated
[78]. Some ribosomal genes are shown to induce the p53 path-
way in response to ribosomal stress. Further studies are neces-
sary to understand the functional significance of the
upregulation of ribosomal genes in PCB-induced toxicity.
In addition to the potential effects on ribosome biogenesis,
PCB126 exposure downregulated genes associated with neuro-
transmitter transport, cytoskeletal network and genes involved
in FoxO, ErbB and mRNA surveillance pathways. FoxO and ErbB
signaling pathways regulate diverse processes including prolif-
eration, differentiation, apoptosis, glucose metabolism and OSR.
Correlation between Altered DNA Methylation and
Altered Gene Expression
One of the important findings from this study is that there is
very little correlation between differential methylation and
gene expression. Similar observations have been made in other
recent studies in different model systems [4, 5, 79–81] suggest-
ing a complex relationship between DNA methylation and gene
expression. Some of the potential reasons for the lack of high
degree of correlation between DNA methylation and gene ex-
pression could be due to the experimental design and bisulfite
sequencing approach used in this study. As DNA methylation
changes precede gene expression changes, it is possible that
one sampling time point may not be adequate to correlate the
changes. In addition, primary and secondary gene expression
changes in response to PCB exposure might be under different
genetic and epigenetic regulatory mechanisms. Futhermore, the
sample size is relatively small and biological variability might
be confounding the results. Even though the eRRBS approach
used in this study is powerful enough to capture the GC-rich ge-
nomic loci, there are several gene promoters that are GC-poor
and are not captured using this approach. Future attempts to
determine the correlation between DNA methylation and gene
expression should consider sampling times carefully and use
WGBS to capture majority of the GC loci in the genome.
Among the small number of genes that showed correlation
include serotonin receptor (htr1aa), vitellogenin (vtg1), deiodi-
nase 2(dio2), a monoxygenase (ywhag1) and a signaling adaptor
molecule (baiap2a) in the liver. These genes play important roles
not only in hepatic function but also regulate growth and repro-
duction. Similarly, the genes that showed correlation in the
brain include a neurotransmitter receptor (grm8a), transcription
factor (klf2b), chaperones (pfdn5, lrpap1), transmembrane glyco-
protein (pmp22a) and a few uncharacterized genes. Some of
these genes have been shown to be altered by PCBs, but there is
no evidence suggesting their regulation by DNA methylation.
Majority of these DMRs are located in the distal promoter re-
gions, suggesting that DMRs are located in the regulatory ele-
ments such as enhancers and insulators, important players in
epigenetic regulation. Even though distal regulatory elements
can be located several kilobases from the core promoter, they
can regulate gene expression via loops in the intervening DNA.
Functional studies have demonstrated that transcription
factor binding can cause demethylation of distal enhancers and
activation of gene expression [82]. Similar studies need to be
conducted to understand the functional relevance of toxicant-
induced DMRs. Recently, thousands of DMRs were identified in
the developing zebrafish genome and a significant portion were
empirically shown to behave as developmental enhancers [27].
It is plausible that the DMRs identified in this study might also
act as enhancers or insulators and regulate gene expression.
Future studies should focus on the functional characterization
of DMRs using CRISPR-Cas technology-based epigenome edit-
ing. The potential candidates for the functional studies would
be those that alter gene expression patterns.
Conclusions
In this study, we demonstrated the effect of a potent AHR ago-
nist (PCB126) on tissue-specific DNA methylation and concomi-
tant gene expression changes in zebrafish. It is known that
some toxicants can alter DNA methylation, but to our knowl-
edge there have been no reports on toxicant effects on genome-
wide DNA methylation and their relationship with gene
expression. Our results suggest that the PCB effects on DNA
methylation are distinct from changes in gene expression. Lack
of correlation between PCB-induced changes in DNA methyla-
tion and gene expression suggests that the relationship be-
tween methylation and gene expression is dynamic and
complex, involving multiple layers of regulation. As DNA meth-
ylation influences gene expression by altering the interaction
between DNA, chromatin and transcription factors, under-
standing the chromatin state will provide insights into the
mechanisms of action. Recent methods such as ATAC (Assay
for Transposase-Accessible Chromatin using sequencing)-seq
and NiCE (Nicking enzyme-assisted sequencing)-seq have en-
abled genome-wide chromatin profiling. Furthermore, time
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course studies should be conducted to determine the spatio-
temporal dynamics of DNA methylation in response to toxicant
exposure. Finally, as zebrafish is extensively used as a toxico-
logical model, it is essential to develop database resources like
ENCODE and an epigenomics portal to catalog genome-wide
studies for future re-analysis and interpretation.
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